Scientists and medical researchers know that the tangible rewards of decades of government investment in solving major health problems is within our grasp, but the promise deserves recognition in the Republican presidential candidate debates.

In 2005, the draft sequence of the human genome was unraveled by an international collaboration at a cost of roughly $5 billion. Today, advances in technology have brought the costs down 5,000-fold to only $1,000. The discoveries of human disease enabled by these advances are simply breathtaking, and we are just now seeing that knowledge being transformed into wisdom, and more importantly, new treatments for dreaded diseases like cancer that will affect 1 in 2 men and 1 in 3 women in this country.

To realize this promise and potential requires research, yet sadly the dollars allocated to the National Institutes of Health are decreasing. Given the rising cost of health care, now more than ever we need to continue to invest in medical research to find new ways of managing disease in more effective and efficient ways.

Investment in medical research is also an investment in our region. At Moffitt Cancer Center, we are unraveling the myriad changes that underlie the transformation of a normal cell into a cancerous one. It’s clear that even cancers that look the same under the microscope can be very different entities that require different treatment strategies. Thus, we are now poised for the first time ever to pursue the goal of cancer therapy that is based on the right drug, for the right patient, at the right time – the first time. (more…)